Of roughly 315 patients at UW Health’s pediatric and adolescent transgender health, or PATH clinic, about 40% are on puberty blockers, estrogen or testosterone. The others haven’t started the treatments or have decided they don’t want them, said Dr. Jennifer Rehm, co-medical director of the clinic.